Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma [PDF]
PURPOSE: This analysis from an observational study of clinical practice describes the impact of febrile neutropenia (FN) on chemotherapy delivery and hospitalizations.
Rossi, F G +46 more
core +1 more source
Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer [PDF]
Background: Febrile neutropenia is a frequently occurring and occasionally life-threatening complication of treatment for childhood cancer. Many biomarkers have been proposed as predictors of adverse events.
Phillips Robert S +19 more
core +2 more sources
C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3′ end modification. [PDF]
C16orf57 encodes a human protein of unknown function, and mutations in the gene occur in poikiloderma with neutropenia (PN), which is a rare, autosomal recessive disease.
Krwawicz, Joanna +6 more
core +1 more source
European surveillance of infections in cancer patients - ESIC [PDF]
Major advances in cancer therapy result from development of multidrug chemotherapy regimens. Besides death from tumor progression, infections are currently one of the major causes of mortality and morbidity.
Krcmery, V. +7 more
core +1 more source
Clinical manifestations and outcomes of pediatric chronic neutropenia
Neutropenia is a decrease in the number of circulating neutrophils. When neutropenia persists for more than 3 months, it becomes chronic. A heterogeneous group of diseases in children can cause chronic neutropenia.
Chuan Wan +7 more
doaj +1 more source
Drug-induced neutropenia in female patient with reactive arthritis
Drug-induced neutropenia is relatively rare, but it is a severe and unfavorable prognostic complication of pharmacotherapy. One of the main causes of drug-induced neutropenia is the use of cytostatic drugs - an integral part of the treatment of many ...
Alexander A. Kopelev +6 more
core +1 more source
Biological treatment in Felty's Syndrome with profound neutropenia
A triad of symptoms characterises Felty's syndrome: seropositive rheumatoid arthritis (RA), splenomegaly and neutropenia. The treatment of Felty's syndrome is based on using classic synthetic and biological disease-modifying drugs (DMARDs).
Marta Madej +3 more
core +1 more source
Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
Objective: Neutropenia is a complication of Graves' disease (GD), but there is currently no means by which to predict its occurrence. This study aimed to investigate the risk factors for the development of neutropenia in untreated GD. Methods: This was
Qian Yang +5 more
doaj +1 more source
Neonatal Diamond-Blackfan anemia with persistent neutropenia caused by an <i>RPS15A</i> variant. [PDF]
Pediatric Investigation, EarlyView.
Zheng H +5 more
europepmc +2 more sources
Clinical spectrum of pediatric neutropenia: mostly benign, but not to be overlooked
Background. Neutropenia is a common laboratory finding in children, therefore it is a common referral reason to pediatric hematology units. This study hypothesizes that most neutropenic children do not require pediatric hematology consultation, and that
Şefika Akyol +3 more
doaj +1 more source

